Against all odds: The evolution of HIV-1-directed broadly neutralizing Antibodies
This project performs advanced sequencing of human B cell repertoires in HIV patients and healthy individuals. In collaboration with projects B3 and B5, these data are used to predict the likelihood to evolve broadly neutralizing antibodies targeting the HIV virus. This likelihood will be compared with antibody effects on HIV populations.
Predictability in Evolution
Collaborative Research Center 1310
Caskey M., Schoofs T., Gruell H., Settler A., Karagounis T., …, Klein F., Nat Med 23, 185-191, 16. January 2017, http://dx.doi.org/10.1038/nm.4268
Schoofs T., Klein F., Braunschweig M., Kreider E.F., Feldmann A. et al., Science 352: 997-1001, 20. May 2016, https://doi.org/10.1126/science.aaf0972